Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JMKX000189 Phase IIa randomized double-blind placebo-controlled dose-finding study in moderate to severe active systemic lupus erythematosus
CTR20231569Phase 2Completed
- Sponsor
- Shanghai Jiyu Medical Technology
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JMKX000189 in systemic lupus erythematosus (SLE), sponsored by Shanghai Jiyu Medical Technology. Started May 2023; status: completed.
02
Drugs
JMKX000189
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20231569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231569.